Longdom Conferences

Speaker

July 22, 2020    London, UK

Webinar on Microbiology and Future Applications

DrElHadji seydou Mbaye
Room1

DrElHadji seydou Mbaye

France

Title: Human Papillomavirus Infection in genital Women in four regions of Senegal

Biography:

Dr. El Hadji Seydou Mbaye was born in 1978 in Kaolack a region of Senegal. During 2008-2013, he earned his PhD in Biology and Human Pathologies with the collaboration of the International Agency for Research on Cancer (IARC) /WHO, Lyon (France); 2006-2007 : Master of Life and Health, Specialty Biology of microorganisms, Virology in Louis Pasteur University of Strasbourg (France); 2005-2006 : Master of Life and Health, option of Immuno-physiopathology in Louis Pasteur University of Strasbourg (France); 2004-2005 : License of Biochemistry in Louis Pasteur University of Strasbourg (France); 2002-2004 : General Degree in Sciences and Technologies in University of METZ (France).

He was certified by the Federation International of Gynecology Obstetrics (FIGO), the Accreditation Council of Oncology in Europe (ACOE, www.acoe.be), the Institute Catalan of Oncology (ICO) for cervical cancer prevention (Grade 10/10) in support of Continuing Medical Education for physicians. These credits are also recognized as Physician’s Recognition Award (AMA PRA Category 1 credits) by the American Medical Association. He was certified, by the United Nations for Basic Notion of Security on the Ground-Protection, Health and behavior, by the International Agency for Research on Cancer (IARC)/World Health Organization, Lyon (France) for Safety Certificate. He has published 1 Book with a style of philosophical story. Author of the world program against cancer in low and middle incomes countries, he is lead author (first listed) of more than 90 peer-reviewed research articles published in reputed journals. He is Review Board Member of Acta Scientific Medical Sciences (ASMS), Acta Scientific Microbiology (ASMI), Research and Reviews on Healthcare: Open Access Journal (RRHOAJ), and Editorial Board Member of the Journal of Medicine and Medical Sciences (JMMS), Modern Journal of Medicine and Biology (MJMB), EC Microbiology, International Journal of Clinical Virology (IJCV), Acta Scientific Cancer Biology (ASCB), BioMed Research Journal (BMRJ), Journal of Medicine and Biology (JMB), Biomedical Research, International journal of vaccines and technologies (IJVT), Journal of Surgery, Operative Techniques and Anaesthesia (JSOTA), Current Research in Bioengineering & Biomedical Sciences (CRBBS), Journal of Women's Health, Gynecology & Obstetrics (JWHGO), Trauma & Emergency Care journal, Journal of Current Medical Research and Opinion (JCMRO), International Journal of Clinical Pharmacology & Pharmacotherapy (IJCPP), Journal of Clinical Microbiology and Infectious Diseases (JCMID), Journal of Retro Virology and Anti Retro Virology (JRVAV), Journal of Antivirals and Antiretrovirals, Research and Reports in Immunology (RRI), Journal of Medical Case Reports and Reviews (JMCRR), Pyrex Journal of Biomedical Research (PJBR), Advances in Immunology and Microbiology (ADIM), Current Scientific Research in Biomedical Sciences (CSRBS), Journal of Clinical & Experimental Immunology (JCEI), Journal of AIDS and HIV Treatment, Edelweiss Journal of AIDS, Journal of HIV and AIDS, Journal of HIV and AIDS Research, Associate Editors for Journal of Bacteriology & Mycology: Open Access (JBMOA), Pediatrics & Neonatal Biology Open Access (PNBOA). Immune & Autoimmune Disorders Journal (IADJ), Annals of Advanced Biomedical Sciences (AABSc) and associate membership of the World Society for Virology, and also, member of BCNet International Working Group, International Agency for Research on Cancer (IARC)/World Health Organization (WHO). Dr MBAYE has formed for free, more than 250 healthcare professionals for the techniques of cervical cancer screening in Senegal. He has appeared on local media, 2S TV, Mbour TV and Leeral.net

Useful Links

News

Coronavirus disease (COVID-19)

2020-03-12

Coronaviruses (CoV) are a large family of viruses that cause illness ranging from the common cold to more severe diseases such as Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS-CoV). A novel coronavirus (nCoV) is a new strain that has not been previously identified in humans. Coronaviruses are zoonotic, meaning they are transmitted between animals and people. Detailed investigations found that SARS-CoV was transmitted from civet cats to humans and MERS-CoV from dromedary camels to humans. Several known coronaviruses are circulating in animals that have not yet infected humans. Common signs of infection include respiratory symptoms, fever, cough, shortness of breath and breathing difficulties. In more severe cases, infection can cause pneumonia, severe acute respiratory syndrome, kidney failure and even death. Standard recommendations to prevent infection spread include regular hand washing, covering mouth and nose when coughing and sneezing, thoroughly cooking meat and eggs. Avoid close contact with anyone showing symptoms of respiratory illness such as coughing and sneezing.

World experts and funders set priorities for COVID-19 research

2020-03-12

Leading health experts from around the world have been meeting at the World Health Organization’s Geneva headquarters to assess the current level of knowledge about the new COVID-19 disease, identify gaps and work together to accelerate and fund priority research needed to help stop this outbreak and prepare for any future outbreaks. The 2-day forum was convened in line with the WHO R&D Blueprint – a strategy for developing drugs and vaccines before epidemics, and accelerating research and development while they are occurring. “This outbreak is a test of solidarity -- political, financial and scientific. We need to come together to fight a common enemy that does not respect borders, ensure that we have the resources necessary to bring this outbreak to an end and bring our best science to the forefront to find shared answers to shared problems. Research is an integral part of the outbreak response,” said WHO Director-General Dr Tedros Adhanom Ghebreyesus. “I appreciate the positive response of the research community to join us at short notice and come up with concrete plans and commitment to work together.” The meeting, hosted in collaboration with GloPID-R (the Global Research Collaboration for Infectious Disease Preparedness) brought together major research funders and over 300 scientists and researchers from a large variety of disciplines. They discussed all aspects of the outbreak and ways to control it including: the natural history of the virus, its transmission and diagnosis; animal and environmental research on the origin of the virus, including management measures at the human-animal interface; epidemiological studies; clinical characterization and management of disease caused by the virus; infection prevention and control, including best ways to protect health care workers; research and development for candidate therapeutics and vaccines; ethical considerations for research; and integration of social sciences into the outbreak response.

Newsletter

© 2024 All Rights Reserved by Longdom